CANNABIS USING SCHIZOPHRENIA PATIENTS TREATED WITH ATYPICAL NEUROLEPTICS: DO THEIR SYMPTOMS DIFFER FROM THOSE OF CANNABIS ABSTAINERS?
Sparad:
SCHAUB, M., ET AL., CANNABIS USING SCHIZOPHRENIA PATIENTS TREATED WITH ATYPICAL NEUROLEPTICS: DO THEIR SYMPTOMS DIFFER FROM THOSE OF CANNABIS ABSTAINERS?. SUBSTANCE USE AND MISUSE, Vol. 43, no. 14 (2008), p. 2045-2052.
Ref.
159271
Placering:
SIIS R.830 Archivo
Palabras clave:
Cannabis, Diagnóstico dual, Drogas ilegales, Drogodependencias, Efectos, Enfermedades mentales, Esquizofrenia, Síntomas
Cannabis, Diagnóstico dual, Drogas ilegales, Drogodependencias, Efectos, Enfermedades mentales, Esquizofrenia, Síntomas
Liknande verk: CANNABIS USING SCHIZOPHRENIA PATIENTS TREATED WITH ATYPICAL NEUROLEPTICS: DO THEIR SYMPTOMS DIFFER FROM THOSE OF CANNABIS ABSTAINERS?
- DO PATIENTS THINK CANNABIS CAUSES SCHIZOPHRENIA? A QUALITATIVE STUDY ON THE CAUSAL BELIEFS OF CANNABIS USING PATIENTS WITH SCHIZOPHRENIA
- CANNABIS AND PREMONITORY SYMPTOMS OF SCHIZOPHRENIA: WHAT IS THE TIME SEQUENCE?
- SYMPTOM DEVELOPMENT IN CHILDHOOD ONSET SCHIZOPHRENIA
- TREATING SUBSTANCE ABUSE IN SCHIZOPHRENIA: AN INITIAL REPORT.
- CANNABIS AND SCHIZOPHRENIA: MODEL PROJECTIONS OF THE IMPACT OF THE RISE IN CANNABIS USE ON HISTORICAL AND FUTURE TRENDS IN SCHIZOPHRENIA IN ENGLAND AND WALES
- CANNABIS CAUSES SCHIZOPHRENIA? SO DOES NICOTINE